Related Experiment Videos

The challenges of treating moderate to severe psoriasis

¹Division of Dermatology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick 08901, USA.

International Journal of Dermatology

|February 18, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Health-related quality of life in patients with generalized pustular psoriasis: A systematic literature review.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy study.

The British journal of dermatology·2021

Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2).

The British journal of dermatology·2020

Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies.

The British journal of dermatology·2020

Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial.

The British journal of dermatology·2019

Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.

The British journal of dermatology·2019

See all related articles